Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
ProMIS Neurosciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer’s Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
Equity Offering 16
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 20
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 21
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 22
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 23
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 24
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 27
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 28
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 29
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 31
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 32
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 33
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 35
ProMIS Neurosciences Inc – Key Competitors 37
ProMIS Neurosciences Inc – Key Employees 38
ProMIS Neurosciences Inc – Locations And Subsidiaries 39
Head Office 39
Recent Developments 40
Financial Announcements 40
Nov 13, 2017: ProMIS Neurosciences Announces Third Quarter 2017 Results 40
Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 42
Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 44
May 09, 2017: ProMIS Neurosciences Announces Q1 2017 Quarterly Results 45
Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 46
Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 47
Nov 02, 2016: ProMIS Neurosciences Announces Third Quarter 2016 Results 49
Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results 51
May 11, 2016: ProMIS Neurosciences announces first quarter 2016 results 53
Mar 23, 2016: ProMIS Neurosciences announces FY2015 year end results 54
Corporate Communications 57
Jun 06, 2017: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board 57
Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 58
Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 59
Oct 18, 2016: ProMIS Neurosciences announces appointment of Dr. Richard Gregory to its Board of Directors 60
Jul 21, 2016: ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer 61
Jan 26, 2016: ProMIS Neurosciences announces formation of prestigious Scientific Advisory and Business Advisory Boards 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63
ProMIS Neurosciences Inc, Medical Equipment, Key Facts, 2016 2
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
ProMIS Neurosciences Inc, Deals By Market, 2011 to YTD 2017 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 20
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 21
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 22
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 23
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 24
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 27
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 28
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 29
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 31
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 32
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 33
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 35
ProMIS Neurosciences Inc, Key Competitors 37
ProMIS Neurosciences Inc, Key Employees 38